David Argue has analyzed competition and performed damages analyses in various health care markets for government merger reviews and private antitrust litigation. Dr. Argue’s recent experience includes trial testimony in FTC v. Otto Bock HealthCare. He also testified at trial in Saint Alphonsus et al. and FTC v. St. Luke’s Health System and before the Utah legislature about healthcare markets in Utah.

He has taught MBA-level courses in the economics of healthcare at the Carey Business School of Johns Hopkins University and authored several articles and presentations on healthcare competition matters. Among the healthcare areas in which Dr. Argue has consulting experience are hospitals, physician practices, ambulatory surgery centers, health insurance, prostheses, and pharmaceuticals. 

Dr. Argue co-authored an article in Antitrust magazine entitled “Cross-Market Health Care Provider Mergers: The Next Enforcement Frontier” (Fall 2015). Among the other articles authored by Dr. Argue are “Reexamining DOJ’s Predation Analysis in United Regional” (Antitrust Health Care Chronicle, January 2012), “An Innovative Approach to an Old Problem: Hospital Merger Simulation” (Antitrust magazine, Fall 2009) and “An Economic Model of Competition Between General Hospitals and Physician-owned Specialty Facilities” (Antitrust Bulletin, Fall-Winter 2007).   

Dr. Argue has also delivered numerous presentations and published other articles on topics involving healthcare economics issues. 

Dr. Argue authored an article entitled “The Deepwater Horizon Oil Spill and Seafood Prices” in the November 2010 issue of Environmental Law Reporter. Previously, he co-authored the book The Economics of a Disaster: The Exxon Valdez Oil Spill.